Lungulescu, C.V.; Camen, G.-C.; Naidin, M.-S.; Berisha, T.-C.; Bita, A.; Dinescu, V.-C.; Buteica, S.A.; Dimulescu, M.-D.; Volovat, S.R.; Turcu-Stiolica, A.
Real-World Efficacy and Adherence to Palbociclib in HR-Positive, HER2-Negative Advanced Breast Cancer: Insights from a Romanian Cohort. Cancers 2024, 16, 4161.
https://doi.org/10.3390/cancers16244161
AMA Style
Lungulescu CV, Camen G-C, Naidin M-S, Berisha T-C, Bita A, Dinescu V-C, Buteica SA, Dimulescu M-D, Volovat SR, Turcu-Stiolica A.
Real-World Efficacy and Adherence to Palbociclib in HR-Positive, HER2-Negative Advanced Breast Cancer: Insights from a Romanian Cohort. Cancers. 2024; 16(24):4161.
https://doi.org/10.3390/cancers16244161
Chicago/Turabian Style
Lungulescu, Cristian Virgil, Georgiana-Cristiana Camen, Mihaela-Simona Naidin, Tradian-Ciprian Berisha, Andrei Bita, Venera-Cristina Dinescu, Sandra Alice Buteica, Marina-Daniela Dimulescu, Simona Ruxandra Volovat, and Adina Turcu-Stiolica.
2024. "Real-World Efficacy and Adherence to Palbociclib in HR-Positive, HER2-Negative Advanced Breast Cancer: Insights from a Romanian Cohort" Cancers 16, no. 24: 4161.
https://doi.org/10.3390/cancers16244161
APA Style
Lungulescu, C. V., Camen, G.-C., Naidin, M.-S., Berisha, T.-C., Bita, A., Dinescu, V.-C., Buteica, S. A., Dimulescu, M.-D., Volovat, S. R., & Turcu-Stiolica, A.
(2024). Real-World Efficacy and Adherence to Palbociclib in HR-Positive, HER2-Negative Advanced Breast Cancer: Insights from a Romanian Cohort. Cancers, 16(24), 4161.
https://doi.org/10.3390/cancers16244161
